OTCPicks.com Stocks to Watch for Monday, September 24th

OTCPicks Publisher Newsletter

OTCPicks.com Stocks to Watch for Monday, September 24th DHRM, OTOW, BPAX, MCLN, APDN, XDSL Our Stocks to Watch today include Dehaier Medical Systems Ltd. (Nasdaq:

DHRM), O2 Secure Wireless Inc. (OTC: OTOW), BioSante Pharmaceuticals Inc.

(Nasdaq: BPAX), MedClean Technologies Inc. (OTCBB: MCLN), Applied DNA Sciences Inc. (OTCBB : APDN) and mPhase Technologies Inc. (OTCBB: XDSL).

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N56&L1&F=T to register for our Stocks to Watch Newsletter and Email Stock Watch Alerts.

DEHAIER MEDICAL SYSTEMS LIMITED (NASDAQ: DHRM) “Up 59.09% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L01&F=T Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).

Dehaier`s technology is based on six patents, nine software copyrights and proprietary technology.

DHRM News:

September 21 – Dehaier Medical Wins Three Year Procurement Agreement from Major Ukrainian Medical Equipment Manufacturer Dehaier Medical Systems Ltd. (Nasdaq: DHRM) (“Dehaier”), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has won a 3-year procurement agreement for Dehaier`s proprietary air compressors and customized trolleys from a major medical equipment manufacturer in Ukraine.

During the three-year term of the agreement, the purchaser will procure Dehaier`s proprietary air compressors, customized trolleys and accessories, which will be used in hospital intensive care units, emergency rooms, operation rooms, respiratory departments and anesthesiology departments.

The purchaser plans to distribute Dehaier products in Ukraine and other European markets through its sales network.

“Since early 2012, Dehaier has made considerable progress in exploring Europe market, mainly due to the grant of CE certification for our air compressor product,” noted Ms. Rayna Dong, Director of Dehaier`s International Marketing. “By actively partnering with distributors, exploring OEM opportunities and attending leading medical equipment exhibitions, we have begun to see the gradual increase of Dehaier`s brand recognition and awareness in Europe. Dehaier`s reputation as a reliable vendor that produces a full line of high quality medical equipment products at reasonable prices enables us to deliver comprehensive, customized solutions to our customers who have to satisfy diverse consumer demands for health care.” O2 SECURE WIRELESS INCORPORATED (OTC: OTOW) “Up 25.00% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L05&F=T O2 Secure Wireless is a Company that is currently developing numerous wireless tower facilities in the U.S. The Company is also instrumental in the development of wireless broadband communication services domestically.

Under a recent merger with Earthcom Service Inc., the Company is currently being structured to provide affordable flat rate pre-paid wireless services in developing countries internationally.

OTOW News:

September 21 – O2 Secure Wireless receives $50 Million Reserve Equity Financing from AGS Capital Group, LLC for the Development of its Building Projects Domestic and Abroad O2 Secure Wireless, Inc. opens retail store and announces staffed call center for growth O2 Secure Wireless, Inc. (OTC: OTOW) announces the opening of its retail store location in Palm Coast, FL at 101 Palm Harbor Pkwy. Unit #133. The store will hold its grand opening on July 9th and will open at 10am. This 1250 Sq. Ft store located in the European Village and is perfectly positioned for the local clientele to find as well as take advantage of the many services that will soon be on the store walls. From wireless services to prepaid MasterCard cards, this store will be one of the cornerstones of our local physical presence in the community. By taking advantage of this retail location, we will be working with local businesses to further encourage consumption of the products issued by our brand. Local merchants can utilize the prepaid card, then not only will their employees save on check-cashing fees, but they`ll be able to reuse these same cards & accounts for relocating and refilling of funds by those they love. We will also be selling phone parts and performing repairs of many of the most common cellular telephones on the market today.

With local word of mouth advertising, and other methods the company will soon announce, we expect that we will have a nice influx of customers into our location to review the products. Direct mail will be sent to retirees in the area to let them know of our debit MasterCard, because in June 2013, the Federal Government has announced that they will cease issuance of paper checks and anyone receiving social security or disability will need to have direct deposit. Our card utilizes FREE direct deposit, so people can take advantage of our card without even having a bank account, which is great for certain, clientele.

In addition to the store opening, OTOW has secured use of an inbound and outbound call team located in the Dominican Republic that will aid in the sale and support of the growth of issuance of the prepaid MasterCard cards.

We expect to be able to ramp up card volume to 1,000 cards per month with a residual income of $50,000 monthly, translated to $6 million yearly, which will immediately be used to finance other projects for growth.

“We are very excited to be able to utilize resources in the Dominican Republic to further grow our presence and it shows our immediate desire to continue to advance our business plans within that country. This call team is currently fielding calls and allows the company to issue cards to those that respond to our corporate advertisements and television commercials.

We`ve kept our financials current on Pink Sheets and will be looking forward to being GREEN in the very near future.” BIOSANTE PHARMACEUTICALS INCORPORATED (NASDAQ: BPAX) “Up 16.67% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L3&F=T BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. BioSante`s lead products include LibiGel (transdermal testosterone gel) in Phase III clinical development by BioSante under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment) for the treatment of female sexual dysfunction (FSD), and Elestrin (estradiol gel) developed through FDA approval by BioSante, indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, currently marketed in the U.S. Also in development are Bio-T-Gel, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate technology (CaP) for novel vaccines, drug delivery and aesthetic medicine (BioLook). Additional information is available online at www.biosantepharma.com.

BPAX News:

September 14 – Top Biotechnology Stock Picks from Oppenheimer & Company Research Analyst The Wall Street Transcript has just published its Biotechnology and Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers.

Topics covered: Biotechnology and Pharmaceutical Valuations – Oncology Drug Development – Orphan Drugs – FDA Approval Process – Reimbursement Trends Companies include: Amgen Inc. (AMGN), Celgene Corporation (CELG), Celldex Therapeutics, Inc. (CLDX), Immunogen Inc. (IMGN), Curis Inc. (CRIS), Pluristem Therapeutics, Inc. (PSTI) and many others.

In the following excerpt from the Biotechnology and Pharmaceuticals Report, an expert analyst discusses the outlook for the sector:

TWST: What are some of the most exciting or promising new drugs, treatments or technologies coming out of your companies right now that investors should be aware of Mr. Peaker: The oncology space is actually very rapidly evolving, so let`s start with oncology first – I think that will be interesting. So oncology, and sometimes I guess in the same field people include immunology, is certainly a rapidly evolving space, where new data is presented quite frequently, and studies often don`t take a very long period of time compared to some other indications, like figuring cholesterol and things like that.

So in the oncology space, some of the interesting new developments are Celldex (CLDX) as a new drug in breast cancer, which is targeting a completely novel target, which is certainly exciting with some of the early stages of development, but the initial data is very encouraging. Speaking of breast cancer, ImmunoGen (IMGN) with their partner Roche (ROG.VX) – I don`t cover Roche, I cover ImmunoGen, but I follow certainly this space.

Also, it`s a very interesting breast cancer drug that shows very, very promising data. Furthermore, in cancer, Curis (CRIS) with its partner Genentech, recently launched a basal cell carcinoma drug, which is very exciting, and while it still needs a little time to figure out how to best use it, the efficacy is very, very encouraging.

On the cell therapy space, which is another area that I cover, there is a company, Pluristem (PSTI), a small company out there. It`s an Israeli-based company that has shown very interesting, certainly initial data, cell therapy treatments that may have broad applications. Let`s say Coronado Biosciences (CNDO) is another one that`s developing potentially breakthrough treatments, which is more in the immunology space, but it`s in Crohn`s, which is a broad indication where there are a lot of drugs that are being tested and are certainly approved. But their approach is very novel, and potentially could change the paradigm of treatment if successful. I don`t know if you want me to bring up more examples, but this is kind of a good start.

Prolor Biotech (PBTH) is another one that I might want to include there. It is a company that I initiated on just today, so I can speak about it already as developing. This is, as I mentioned, I have oncology and some orphan diseases, but a few companies out there that are, don`t fit into any particular category, and so what they`re developing, Prolor is developing a delayed-release growth hormone. So as you may know, growth hormone is used in a wide range of indications, some labeled and some are not labeled. And typically, every growth hormone that`s available out there requires daily injection. Prolor`s technology shows that their version of growth hormone is effective and may be given once a week, maybe every two weeks, but for now at least once a week. And we think it could be a game changer for the growth hormone market, which is well established at this point.

MEDCLEAN TECHNOLOGIES INCORPORATED (OTCBB: MCLN) “Up 100.00% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L74&F=T MedClean Technologies, Inc. is a provider of innovative technology and services for the treatment and disposal of regulated medical waste.

MedClean`s flagship MedClean Series systems are fully integrated, turnkey technology solutions that enable healthcare providers and medical waste haulers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities now located in Bethlehem, Pennsylvania.

MCLN News:

No recent news for MedClean Technologies, Inc. (OTCBB: MCLN).

APPLIED DNA SCIENCES INCORPORATED (OTCBB: APDN) “Up 21.14% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L9&F=T APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators.

APDN News:

September 18 – Applied DNA Sciences Contracts With Inventionland Development Agreement on Novel Loss-Prevention Products Incorporating DNA Platforms Applied DNA Sciences, Inc. (OTCBB: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has entered into a Development Agreement with Inventionland Corporation. The two companies will collaborate on the development of innovative loss-prevention products, based upon APDN`s botanical DNA-marking platform. Inventionland will participate in product development with APDN and take the resultant new products and applications to its customers.

The agreement between APDN and Inventionland follows closely the launch by APDN of smartDNA, a system designed to mark offenders and to prevent theft. The system has been deployed internationally to protect banks, retailers, jewelers and pharmacies. APDN also launched its digitalDNA platform this year that combines DNA-based security with secure-cloud technology, mobile computing and authentication on-the-fly.

Inventionland Corporation is America`s largest invention factory. Over 1,000 different retailers and on-line stores have sold its innovations.

Inventionland builds 2,000-2,400 new product samples for corporations and retailers to review for their shelves each year. With some retailers facing large asset loss from their stores, Inventionland was asked to invent new products to help eliminate loss in a more innovative and effective manner.

Inventionland`s founder, George Davison, is an APDN stockholder. After Mr.

Davison contacted APDN, both organizations began collaborating to offer a retailer solution that would help eliminate asset loss.

Mr. Davison, renowned for his novel approaches to product development, and himself the subject of a profile on the U.S. cable TV channel History (formerly The History Channel), stated: “I was a long-standing fan of Applied DNA Sciences` novel technology and enormous breadth of application, as well as Dr. Hayward`s already-validated approach to managing biotechnology development. Inventionland is now pleased to be able to take this platform to our market-leading retailers.” Dr. Hayward commented: “Biotech companies can benefit from Inventionland`s innovative approach and unmatchable speed-to-market. We are thrilled to partner with Inventionland on some very original and unique applications for DNA marking.” ABOUT INVENTIONLAND Inventionland is America`s largest invention factory, Inventionland, turns out 2,000-2,400 new inventions each year. Employees at Inventionland work in 16 unique themed sets, such as a shipwrecked pirate ship, a faux cave, a giant robot and a castle complete with turrets and drawbridge. The inspiring setting includes three running waterfalls, life-like trees and butterflies and chirping birds. In the rear of Inventionland is a red carpet that leads to a state-of-the art audio, video, and animation studio complete with sound room and one of the largest green screens in the tri-state area. Metalworking, woodworking, molding, laser cutting, prototyping, circuit board construction, and more take place in a state-of-the-art product sample construction facility. Hundreds of new ideas come to life every month at Inventionland, where Davison`s award-winning team sets an example of America`s can-do spirit and ingenuity.

MPHASE TECHNOLOGIES INCORPORATED (OTCBB: XDSL) “Up 16.67% on Friday” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N56&L&F=T mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website at www.mpowertech.com.

XDSL News:

September 13 – mPhase Technologies Receives Notice of Allowance for Modular Device Patent mPhase Technologies, Inc. (OTCBB: XDSL) reported that it has received a Notice of Allowance from the U.S. Patent & Trademark Office (USPTO) for a Modular Device patent.

The invention generally relates to a handheld, powered device containing at least one power module having at least one battery, wherein the power module is removable and separately connects to each of the load modules.

More specifically it relates to a modular device for providing multiple modular components that may be interchanged as desired. A system for providing a modular device for use in emergency or everyday applications and having a plurality of modular components that are interchangeable with one another depending on the particular desired use.

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N56&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N56&L=8&F=T.

Disclosure: OTCPicks.com is not currently being compensated by any of the companies covered in this release.